|
Chromatin Licenses Gene Stacking Technology for Sugar cane to Syngenta
June 26, 2009
CHICAGO—(BUSINESS WIRE) – Chromatin Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin’s proprietary gene stacking technology in sugar cane. |
|
State of Illinois launches 2009 Innovate Illinois competition
June 25, 2009
The Illinois DCEO today launched the fifth annual Innovate Illinois competition. Innovate Illinois is designed to recognize high-growth businesses in Illinois. |
|
PROPEL Intel - June 2009
June 23, 2009
PROPEL Intel is a monthly e-newsletter for entrepreneurs, early stage life sciences companies and others in the community who work with PROPEL and the iBIO Entrepreneurship Center.
|
|
PROPEL Turns 2! Illinois Startup Executives Discuss PROPEL Impact in Next Issue of BQ
June 19, 2009
June 20, 2009 marked the two-year anniversary of PROPEL, a joint partnership of iBIO and the iBIO Institute. PROPEL comprises a series of programs aimed at increasing the number of life sciences startups in Illinois and boosting the success rates of existing companies. |
|
A Special Progress Report: The Emerging Technology Industries Act (SB 1522)
June 19, 2009
I promised in our last issue to give you an update on the Emerging Technology Industries Act, better known as SB 1522. Before debrief, I must thank many of you for a remarkable effort. A great deal of time, energy, and passion. I am proud to be associated with your good work. |
|
iBIO President's Letter 05/09: Let’s Prepare a Midwest Welcome to the Biotech World!
May 29, 2009
Last week, the iBIO and iBIO Institute staffs went to Atlanta to join Midwest community members participating in a vibrant and well-executed BIO International Convention. For me, it was initially a tough trip, tearing myself away from the intensive statewide effort to pass SB 1522 in support of high technology startups |
|
PROPEL Intel - May 2009
May 29, 2009
PROPEL Intel is a monthly e-newsletter for entrepreneurs, early stage life sciences companies and others in the community who work with PROPEL and the iBIO Entrepreneurship Center. |
